Daily as of 3 Nov 16:00 ET
- Price
- below both $62.31 vs 50 $66.91 / 200 $70.07
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 19 Oct 2026 · projected 30 bars out
CYTK | CytokineticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$62.31
+$0.28 (+0.45%)
Cytokinetics (CYTK) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $62.99 vs 50 $68.91 / 200 $52.85
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 2 Feb 2026 · projected 28 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $62.31 vs 50 $62.77 / 200 $73.33
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 9 Sep 2026 · projected 14 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 19 Oct 2026 | 💀Death steep | daily | 30 bars out | Not tested |
| 9 Sep 2026 | 💀Death | 4-hour | 14 bars out | — |
| 17 Apr 2026 | 🟨Golden | 4-hour | 18 bars out | 1 bar cross test |
| 23 Mar 2026 | 💀Death | 4-hour | 24 bars out | 3 bar cross test |
| week of 2 Feb 2026 | 🟨Golden moderate | weekly | 28 bars out | Not tested |
About CYTK
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$118M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge